Current Opinion in Lipidology

Papers
(The TQCC of Current Opinion in Lipidology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Editorial introductions74
Familial hypercholesterolemia-Plus: is the metabolic syndrome changing the clinical picture of familial hypercholesterolemia?62
Sphingomyelins and ceramides: possible biomarkers for dementia?60
Ups and downs in PCSK9 inhibition in the cardiovascular arena: a review56
ANGPTL4: a new mode in the regulation of intravascular lipolysis53
Angiopoietin-like protein 8: a multifaceted protein instrumental in regulating triglyceride metabolism42
Triglyceride-rich lipoproteins, remnant-cholesterol, and atherosclerotic cardiovascular disease39
Alveolar macrophages: guardians of the alveolar lipid galaxy37
Genetic variation in apolipoprotein A-V in hypertriglyceridemia34
The lipid-heart hypothesis from the Seven Countries Study of Cardiovascular Diseases32
Oxidized LDL receptors: a recent update31
Familial hypercholesterolemia in children and the importance of early treatment24
Lipoprotein(a) and peripheral artery disease: contemporary evidence and therapeutic advances19
Familial hypercholesterolemia: The nexus of endothelial dysfunction and lipoprotein metabolism in COVID-1918
Exosomes and lipid metabolism in metabolic and cardiovascular disorders18
Universal screening for familial hypercholesterolaemia: how can we maximise benefits and minimise potential harm for children and their families?17
Implementation science and genetic testing for familial hypercholesterolemia17
Lipid metabolism during pregnancy: consequences for mother and child16
Editorial introductions16
Genetic determinants of pancreatitis risk in hypertriglyceridemia15
Nonalcoholic fatty liver disease: an update15
A new SPRING in lipid metabolism15
The current state of apolipoprotein E in dyslipidemia14
The need for national and international registries of patients with elevated lipoprotein(a)14
Nutrition and its impact on cardiovascular disease14
ANGPTL3 and ApoC-III inhibitors for treating hypertriglyceridemia in context: horses for courses?14
The complex pro-atherosclerotic role of lipoprotein(a): a multiplicity of cellular targets14
Familial hypercholesterolemia in pregnancy14
The intracellular chylomicron highway: novel insights into chylomicron biosynthesis, trafficking, and secretion14
From clinical development to real-world outcomes with inclisiran13
Editorial introductions13
High-density lipoprotein functionality, cardiovascular health, and patterns of alcohol consumption: new insights and future perspectives13
APOE and familial hypercholesterolemia13
Evolving guidelines on lipoprotein(a)12
Are the lipid-lowering effects of incretin-based therapies relevant for cardiovascular benefit?12
Editorial introductions11
In the wake of the Scandinavian Simvastatin Survival Study trial11
Can small dense LDL cholesterol be estimated from the lipid profile?11
Cardiomyocytes, sphingolipids and cardio myotoxicity11
Inclisiran: present and future perspectives of a new effective LDL cholesterol-lowering agent11
The emerging role of fat-inducing transcript 2 in endoplasmic reticulum proteostasis and lipoprotein biogenesis11
Distinct roles of size-defined HDL subpopulations in cardiovascular disease10
Newborn screening for lipid disorders10
Beyond cholesterol: linking the conformation of apolipoprotein B to atherogenesis10
The expanding role of lyso-phosphatidylcholine acyltransferase-3 (LPCAT3), a phospholipid remodeling enzyme, in health and disease9
Clinical associations between exercise and lipoproteins9
Genetic testing for familial hypercholesterolemia9
Pregnancy, cardiovascular health, and microchimerism9
Strategies for management of patients with elevated lipoprotein(a)9
Association of dietary patterns and components with atherosclerosis risk biomarkers in familial hypercholesterolemia9
0.027880907058716